Investigating PREVENT-19 trial findings of serological correlates of immune safety and danger towards COVID-19
In a current evaluate posted to the medRxiv* preprint server, researchers introduced the PREVENT-19 [refusion protein subunit vaccine efficacy Novavax trial–coronavirus disease 2019 (COVID-19)] section 3 trial findings on the effectiveness of the NVX-CoV2373 (Novavax) adjuvanted, recombinant S nanoparticle vaccine. Study: Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial. Image Credit: CROCOTHERY/Shutterstock … Read more